GFAP and Alzheimer disease: In this study, we aimed to investigate the impact of kidney impairment on a broad range of AD plasma biomarkers, including Aβ40, Aβ42, GFAP, NfL, p-tau181, p-tau217, p-tau231, and NTA-tau.